| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.3 | 0.04 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.1 | 0.05 |